First humans test new Drug's safety
NCT ID NCT07035769
Summary
This is a very early, first-in-human study to check the safety and how the body processes a new oral drug called Debio 1453P. It will involve 88 healthy adults who will receive either the drug or a placebo. The main goal is to see how well different doses are tolerated and to measure the drug levels in the blood and urine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SGS Belgium NV - Clinical Pharmacology Unit
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.